Literature DB >> 8977281

Antigen-independent responsiveness to interleukin-4 demonstrates differential regulation of newborn human T cells.

E M Early1, D J Reen.   

Abstract

The low incidence of graft-versus-host disease following clinical use of umbilical cord blood compared to adult bone marrow as a source of stem cells for bone marrow reconstitution, leads to questions concerning the level of immunocompetence of newborn T cells. The maturation and functional status of newborn CD4+ T cells, which are almost exclusively CD45RA+ naive T cells, compared with their adult phenotypic counterparts, is poorly understood. We examined the proliferative response to mitogens and cytokines of CD4/CD45RA+ T cells from adults and newborns, with and without accessory cells. Newborn CD4/CD45RA+ T cells demonstrated a distinct proliferative response profile which was determined by the number of accessory cells present in co-cultures with various stimuli. Newborn CD4/CD45RA+ T cells were particularly responsive to interleukin (IL)-4, IL-4 plus anti-CD2 monoclonal antibodies (mAb) and IL-4 plus phytohemagglutinin (PHA), whereas adult CD4/CD45RA+ T cells were unresponsive under similar conditions. The mitogenic responses of newborn and adult CD4/CD45RA+ T cells to PHA and anti-CD2 mAb, which were equivalent, were directly proportional to the number of accessory cells present, whereas the responsiveness to cytokines was inversely proportional to the number of co-cultured accessory cells. Anti-CD2 responses were much more sensitive to low numbers of accessory cells than PHA. The particular sensitivity of newborn CD4/CD45RA+ T cells to IL-4 represents an antigen-independent T cell activation response which could help promote a Th2 immune response resulting in the newborn.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8977281     DOI: 10.1002/eji.1830261212

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  8 in total

Review 1.  Immune mechanisms of childhood asthma.

Authors:  C E Donovan; P W Finn
Journal:  Thorax       Date:  1999-10       Impact factor: 9.139

2.  Rapid conversion of naive to effector T cell function counteracts diminished primary human newborn T cell responses.

Authors:  E Early; D J Reen
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

3.  Progressive polarization towards a T helper/cytotoxic type-1 cytokine pattern during age-dependent maturation of the immune response inversely correlates with CD30 cell expression and serum concentration.

Authors:  M Krampera; F Vinante; L Tavecchia; L Morosato; M Chilosi; S Romagnani; M E Zanolin; G Pizzolo
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

4.  Transfer of maternal cytokines to suckling piglets: in vivo and in vitro models with implications for immunomodulation of neonatal immunity.

Authors:  Trang V Nguyen; Lijuan Yuan; Marli S P Azevedo; Kwang-Il Jeong; Ana-Maria Gonzalez; Linda J Saif
Journal:  Vet Immunol Immunopathol       Date:  2007-03-01       Impact factor: 2.046

5.  Cord blood CD4+ CD45RA+ T cells achieve a lower magnitude of activation when compared with their adult counterparts.

Authors:  J Hassan; D J Reen
Journal:  Immunology       Date:  1997-03       Impact factor: 7.397

6.  Differential cytokine regulation of natural killer cell-mediated necrotic and apoptotic cytotoxicity.

Authors:  C M Gardiner; D J Reen
Journal:  Immunology       Date:  1998-04       Impact factor: 7.397

7.  Insulin-like growth factor I promotes cord blood T cell maturation through monocytes and inhibits their apoptosis in part through interleukin-6.

Authors:  Helen K W Law; Wenwei Tu; Enmei Liu; Yu Lung Lau
Journal:  BMC Immunol       Date:  2008-12-17       Impact factor: 3.615

Review 8.  Training the Fetal Immune System Through Maternal Inflammation-A Layered Hygiene Hypothesis.

Authors:  April C Apostol; Kirk D C Jensen; Anna E Beaudin
Journal:  Front Immunol       Date:  2020-02-11       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.